培養(yǎng)基含有ITS+E，EGF，胰島素、氫化可的松、腎上腺激素、鐵傳遞蛋白和CaCl2，微量元素，抗生素等，適用于HK-2細(xì)胞，rwpe-1，rwpe-2等角質(zhì)無(wú)血清培養(yǎng)的細(xì)胞系列，也可用于原代無(wú)血清角質(zhì)細(xì)胞的培養(yǎng)，若從有血清更換成無(wú)血清培養(yǎng)方式需要階梯式更換，可更好的保證細(xì)胞的質(zhì)量。

培養(yǎng)基配方：

基礎(chǔ)培養(yǎng)基KSFM(貨號(hào)：P8000)：500ml  ，細(xì)胞生長(zhǎng)因子KSFGS(貨號(hào)：P8002)：5ml ，G/A（貨號(hào)：SD0038）：5ml。

備注：100ml瓶裝無(wú)套件，為整瓶配制。

聲明：僅供科研使用。

1. Randomized Controlled Trial Assessing the Efficacy and Safety of a Liposomal Carrier for Low-Dose Dual Antiplatelet Therapy (Clopidogrel and Aspirin) in Coronary Heart Disease Patients

https://doi.org/10.1016/j.clinthera.2025.01.018

2. Puerarin Attenuates Myocardial Ischemia-Reperfusion Damage by Targeting Ferroptosis through 14-3-3η Modulation. DOI:10.3969/j.issn.2097-2806.2025.06.01

3.CRISPR/Cas12a, combined with recombinase polymerase amplification (RPA) reaction for visual detection of Leishmania species，https://doi.org/10.1016/j.microc.2024.112283

4. 磷脂酰膽堿包裹的白藜蘆醇增強(qiáng)皮膚抗氧化和 抗皺能力研究.China Surfactant Detergent & Cosmetics (2097-2806), 2025, Vol 55, Issue 6, p756

https://10.3969/j.issn.2097-2806.2025.06.0

5.Deng, Z.; Shen, Q.; Deng, N.; Wu, J.; Cheng, X.; Wang, J.; Peng, H.; Zeng, W.; Song, Z.; Jiang, D.; et al. CircATP2C1 Drives Prostate Cancer Progression Through miR-654-3p-Mediated SLC7A11 Upregulation and Ferroptosis Suppression. Cancers 2025, 17, 3571. https://doi.org/10.3390/cancers17213571

6.Deng, Z.; Shen, Q.; Deng, N.; Wu, J.; Cheng, X.; Wang, J.; Peng, H.; Zeng, W.; Song, Z.; Jiang, D.; et al. CircATP2C1 Drives Prostate Cancer Progression Through miR-654-3p-Mediated SLC7A11 Upregulation and Ferroptosis Suppression. Cancers 2025, 17, 3571.  https://doi.org/10.3390/cancers17213571